MSH Release-Inhibiting Hormone [hormon inhibující uvolňování MSH]
- Terms
-
melanostatin
prolyl-leucyl-glycinamid
-
H-Pro-Leu-Gly-NH2
Melanocyte-Stimulating Hormone Release-Inhibiting Factor
Melanocyte-Stimulating Hormone Release-Inhibiting Hormone
Melanostatin
MIF-1
MIF-I
MSH Release-Inhibiting Factor
Oxytocin (7-9)
Pro-Leu-Gly-NH2
Pro-Leu-Glyamide
Prol-Leu-Gly-NH2
Prolyl-Leucyl-Glycinamide
Prolylleucylglycinamide
A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES.
- DUI
- D009075 MeSH Browser
- CUI
- M0014157
- Previous indexing
- Oligopeptides (1973-1974); Hypothalamo-Hypophyseal System (1966-1974); Hypothalamus (1966-1974); MSH (1966-1974); Peptides (1971-1973); Pituitary Hormone-Releasing Hormones (1971-1974)
- History note
- 75
- Public note
- 75
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives 4
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 2
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine